Neuropsychopharmacology

Ipsapirone, a 5-HT_1A Agonist, Suppresses REM Sleep Equally in Unmedicated Depressed Patients and Normal Controls
pp. 109-115(7)
Authors: Gillin J.C.; Jin-Wook S.; Stahl S.M.; Lardon M.; Kelsoe J.; Rapaport M.; Ruiz C.; Golshan S.

Effects of the Selective 5-HT_2A Receptor Antagonist MDL 100,907 on MDMA-Induced Locomotor Stimulation in Rats
pp. 116-124(9)
Authors: Kehne J.H.; Ketteler H.J.; McCloskey T.C.; Sullivan C.K.; Dudley M.W.; Schmidt C.J.

The Effects of Ethanol on Striatal Dopamine and Frontal Cortical D-[³H]Aspartate Efflux Oscillate with Repeated Treatment - Relevance to Individual Differences in Drug Responsiveness
pp. 125-132(8)
Authors: Caggiula A.R.; Antelman S.M.; Palmer A.M.; Kiss S.; Edwards D.J.; Kocan D.

Cerebral Metabolism of Imipramine and a Purified Flavin-Containing Monooxygenase from Human Brain
pp. 133-142(10)
Authors: Bhagwat S.V.; Bhamre S.; Boyd M.R.; Ravindranath V.

Chronic Citalopram and Fluoxetine Treatments Upregulate 5-HT_2C Receptors in the Rat Choroid Plexus
pp. 143-151(9)
Authors: Laakso A.; Palvimaki E.-P.; Kuoppamaki M.; Syvalahti E.; Hietala J.

Genetic Correlation of Inhibitory Gating of Hippocampal Auditory Evoked Response and -Bungarotoxin-Binding Nicotinic Cholinergic Receptors in Inbred Mouse Strains
pp. 152-162(11)
Authors: Stevens K.E.; Freedman R.; Collins A.C.; Hall M.; Leonard S.; Marks M.J.; Rose G.M.

Differential Response to the Cholinergic Agonist Arecoline among Different Cognitive Modalities in Alzheimer's Disease
pp. 163-170(8)
Authors: Raffaele K.C.; Asthana S.; Berardi A.; Haxby J.V.; Morris P.P.; Schapiro M.B.; Soncrant T.T.

Dichotic Listening before and after Fluoxetine Treatment for Major Depression: Relations of Laterality to Therapeutic Response
pp. 171-179(9)
Authors: Bruder G.E.; Otto M.W.; McGrath P.J.; Stewart J.W.; Fava M.; Rosenbaum J.F.; Quitkin F.M.

G-Protein Level Quantification in Platelets and Leukocytes from Patients with Panic Disorder
pp. 180-186(7)
Authors: Stein M.B.; Guang C.; Potter W.Z.; Manji H.K.

Seasonal Variation in Platelet [³H]Paroxetine Binding in Healthy Volunteers - Relationship to Climatic Variables
pp. 187-198(12)
Authors: D'Hondt P.; Maes M.; Leysen J.E.; Gommeren W.; Heylen L.; DeMeyer F.; Scharpe S.; Peeters D.; Desnyder R.

Anxiolytic Activity of Intraventricularly Administered Atrial Natriuretic Peptide in the Rat
pp. 199-206(8)
Authors: Bhattacharya S.K.; Chakrabarti A.; Sandler M.; Glover V.

Naloxone-Induced Pituitary-Adrenal Activation Does Not Differ in Patients with Depression, Obsessive Compulsive Disorder, and Healthy Controls
pp. 207-212(6)
Authors: Michelson D.; Altemus M.; Galliven E.; Hill L.; Greenberg B.D.; Gold P.